1. Home
  2. NTZ vs FEMY Comparison

NTZ vs FEMY Comparison

Compare NTZ & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natuzzi S.p.A.

NTZ

Natuzzi S.p.A.

HOLD

Current Price

$3.12

Market Cap

34.3M

ML Signal

HOLD

Logo Femasys Inc.

FEMY

Femasys Inc.

HOLD

Current Price

$0.43

Market Cap

37.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTZ
FEMY
Founded
1959
2004
Country
Italy
United States
Employees
N/A
N/A
Industry
Home Furnishings
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.3M
37.2M
IPO Year
1998
2021

Fundamental Metrics

Financial Performance
Metric
NTZ
FEMY
Price
$3.12
$0.43
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$5.50
AVG Volume (30 Days)
6.1K
577.6K
Earning Date
04-13-2023
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
44.71
EPS
N/A
N/A
Revenue
N/A
$2,293,313.00
Revenue This Year
N/A
$183.83
Revenue Next Year
N/A
$196.80
P/E Ratio
N/A
N/A
Revenue Growth
N/A
40.77
52 Week Low
$2.15
$0.31
52 Week High
$5.00
$1.29

Technical Indicators

Market Signals
Indicator
NTZ
FEMY
Relative Strength Index (RSI) 52.72 40.76
Support Level $3.07 $0.33
Resistance Level $3.20 $0.58
Average True Range (ATR) 0.24 0.05
MACD 0.01 -0.00
Stochastic Oscillator 86.44 45.56

Price Performance

Historical Comparison
NTZ
FEMY

About NTZ Natuzzi S.p.A.

Natuzzi SpA is an Italian firm that designs, manufactures, and sells contemporary and traditional leather and fabric-upholstered furniture. Its product portfolio includes sofas, loveseats, armchairs, sectional furniture, motion furniture and sofa beds, living room furnishings, and accessories. The company markets its products under several brands such as Natuzzi Italia, Private label, and Natuzzi Editions. Geographically, it derives a majority of its revenue from the United States of America and also has an international presence in Italy, Spain, the UK, China, and Other countries.

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

Share on Social Networks: